Robert E. Shiel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Robert E. Shiel has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Carmel T. Mooney
School of Veterinary Medicine, University College Dublin, Dublin 4, Ireland
5 shared publicationsCarmel T Mooney
Small Animal Clinical Studies, University College Dublin School of Veterinary Medicine , Dublin
3 shared publications- Adrien Joaquim Da Silva
Small Animal Clinical Studies UCD School of Veterinary Medicine University College Dublin Dublin Ireland
1 shared publication - Antonella Puggioni
School of Veterinary Medicine, University College Dublin, Dublin, Ireland
1 shared publication - Barbara A. Gallagher
Present Address: Chestergates Veterinary Specialists, Telford Court Chestergates Roads Chester, Cheshire, CH1 6LT, UK
1 shared publication C. M. Nolan
School of Biology and Environmental Science University College Dublin, Belfield Dublin 4 Ireland
1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (5)
Evaluation of basal cortisol and the adrenocorticotropic hormone stimulation test in 982 dogs undergoing investigation for hypoadrenocorticism
Background: The adrenocorticotropic hormone (ACTH) stimulation test is the gold standard test for diagnosing hypoadrenocorticism. However, basal cortisol is recommended for screening but fails to consider the effect of analytical variation and previous glucocorticoid therapy on test performance and additional information that a stimulation test could provide. Hypothesis/Objectives: To investigate the effect of varied cut-offs and previous glucocorticoid therapy on the diagnostic performance of basal cortisol and whether ACTH stimulation test results impart additional prognostic information. Animals: Fifty-five and 927 hospitalized dogs with and without hypoadrenocorticism, respectively. Methods: Retrospective case record analysis of dogs undergoing ACTH stimulation testing. Cortisol concentrations were compared between glucocorticoid-exposed (GS, n = 198) and non-exposed (NGS, n = 729) groups. Results: Basal cortisol concentrations ≤ 2.0 μg/dL were significantly (P < .0001) more common in the GS (n = 91, 46.0%) than in the NGS group (n = 226, 31.0%). False-positive flat-line ACTH stimulation test results occurred in 11 (1.2%) dogs. Basal cortisol ≤ 2.0 μg/dL demonstrated imperfect diagnostic sensitivity (98.2%; 95% CI, 90.3%-100%) and poor specificity (65.8%; 95% CI, 62.7%-68.9%). Increasing the cut-off from 2.0 to 2.4, 2.7, or 3.1 μg/dL improved diagnostic sensitivity at the expense of specificity. In the NGS group, basal > 7.0 μg/dL, post-ACTH > 15.6 μg/dL, and delta < 5.3 μg/dL cortisol concentrations were associated with increased risk of not surviving to discharge. Conclusions and clinical importance: Higher basal cortisol concentration cut-offs (>2 μg/dL) maximize test sensitivity to the detriment of specificity. Adrenocorticotropic hormone stimulation test results rule out hypoadrenocorticism in the majority of dogs and can provide prognostic information.
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 40 (5)
Open AccessEvaluation of basal cortisol and the adrenocorticotropic hormone stimulation test in 982 dogs undergoing investigation for hypoadrenocorticism
Background: The adrenocorticotropic hormone (ACTH) stimulation test is the gold standard test for diagnosing hypoadrenocorticism. However, basal cortisol is recommended for screening but fails to consider the effect of analytical variation and previous glucocorticoid therapy on test performance and additional information that a stimulation test could provide. Hypothesis/Objectives: To investigate the effect of varied cut-offs and previous glucocorticoid therapy on the diagnostic performance of basal cortisol and whether ACTH stimulation test results impart additional prognostic information. Animals: Fifty-five and 927 hospitalized dogs with and without hypoadrenocorticism, respectively. Methods: Retrospective case record analysis of dogs undergoing ACTH stimulation testing. Cortisol concentrations were compared between glucocorticoid-exposed (GS, n = 198) and non-exposed (NGS, n = 729) groups. Results: Basal cortisol concentrations ≤ 2.0 μg/dL were significantly (P < .0001) more common in the GS (n = 91, 46.0%) than in the NGS group (n = 226, 31.0%). False-positive flat-line ACTH stimulation test results occurred in 11 (1.2%) dogs. Basal cortisol ≤ 2.0 μg/dL demonstrated imperfect diagnostic sensitivity (98.2%; 95% CI, 90.3%-100%) and poor specificity (65.8%; 95% CI, 62.7%-68.9%). Increasing the cut-off from 2.0 to 2.4, 2.7, or 3.1 μg/dL improved diagnostic sensitivity at the expense of specificity. In the NGS group, basal > 7.0 μg/dL, post-ACTH > 15.6 μg/dL, and delta < 5.3 μg/dL cortisol concentrations were associated with increased risk of not surviving to discharge. Conclusions and clinical importance: Higher basal cortisol concentration cut-offs (>2 μg/dL) maximize test sensitivity to the detriment of specificity. Adrenocorticotropic hormone stimulation test results rule out hypoadrenocorticism in the majority of dogs and can provide prognostic information.
- Open Access
- 21 May 2025
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (3)
Focal myasthenia gravis in a 4‐year‐old Chihuahua cross dog presented for apparent vomiting
A 4‐year‐old, female, neutered Chihuahua cross was presented with a history of chronic apparent vomiting and coughing. Upon further questioning, regurgitation was suspected rather than vomiting. Conscious thoracic radiographs revealed generalised megaoesophagus. The dog was diagnosed with focal myasthenia gravis based on a positive acetylcholine receptor antibody titre 2.33 nmol/L (<0.6 nmol/L). The dog responded to pyridostigmine treatment (0.5 mg/kg every 12 hours, increasing to 1.6 mg/kg every 12 hours) with reduced frequency of regurgitation episodes. In this case, differentiation between vomiting and regurgitation was crucial for appropriate diagnostic testing and treatment. Pyridostigmine is the treatment of choice for both focal and generalised myasthenia gravis. The dose must be titrated to control clinical signs in both forms of the disease.
- 21 May 2025
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (3)
Open AccessFocal myasthenia gravis in a 4‐year‐old Chihuahua cross dog presented for apparent vomiting
A 4‐year‐old, female, neutered Chihuahua cross was presented with a history of chronic apparent vomiting and coughing. Upon further questioning, regurgitation was suspected rather than vomiting. Conscious thoracic radiographs revealed generalised megaoesophagus. The dog was diagnosed with focal myasthenia gravis based on a positive acetylcholine receptor antibody titre 2.33 nmol/L (<0.6 nmol/L). The dog responded to pyridostigmine treatment (0.5 mg/kg every 12 hours, increasing to 1.6 mg/kg every 12 hours) with reduced frequency of regurgitation episodes. In this case, differentiation between vomiting and regurgitation was crucial for appropriate diagnostic testing and treatment. Pyridostigmine is the treatment of choice for both focal and generalised myasthenia gravis. The dose must be titrated to control clinical signs in both forms of the disease.
- 1 February 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (2) , 1-3
Pathology in Practice
"Pathology in Practice" published on 31 Oct 2022 by American Veterinary Medical Association.
- 1 February 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (2) , 1-3
Pathology in Practice
"Pathology in Practice" published on 31 Oct 2022 by American Veterinary Medical Association.
- Open Access
- 4 March 2022
- Published by Springer Nature in Canine Medicine and Genetics
- Vol. 9 (1) , 1-2
Correction to: Insulins for the long term management of diabetes mellitus in dogs: a review
- 4 March 2022
- Published by Springer Nature in Canine Medicine and Genetics
- Vol. 9 (1) , 1-2
Open AccessCorrection to: Insulins for the long term management of diabetes mellitus in dogs: a review
- Open Access
- 14 February 2022
- Published by Springer Nature in Canine Medicine and Genetics
- Vol. 9 (1) , 1-11
Insulins for the long term management of diabetes mellitus in dogs: a review
The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.
- 14 February 2022
- Published by Springer Nature in Canine Medicine and Genetics
- Vol. 9 (1) , 1-11
Open AccessInsulins for the long term management of diabetes mellitus in dogs: a review
The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.
- Open Access
- 1 July 2021
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 76, 106623
Qualitative and semiquantitative assessment of thyroid hormone binding proteins in greyhounds and other dog breeds
- 1 July 2021
- Published by Elsevier in Domestic Animal Endocrinology
- Vol. 76, 106623
Open AccessQualitative and semiquantitative assessment of thyroid hormone binding proteins in greyhounds and other dog breeds
- Open Access
- 1 April 2019
- Published by British Small Animal Veterinary Association
- p. 476
Evaluation of alterations in mean platelet volume in dogs with pancreatitis
BSAVA library: We promote excellence in small animal practice through education and science. Online Library contains Manuals, Guides, Formularies and other content from the BSAVA.
- 1 April 2019
- Published by British Small Animal Veterinary Association
- p. 476
Open AccessEvaluation of alterations in mean platelet volume in dogs with pancreatitis
BSAVA library: We promote excellence in small animal practice through education and science. Online Library contains Manuals, Guides, Formularies and other content from the BSAVA.
- 2 March 2019
- Published by Mark Allen Group in Companion Animal
- Vol. 24 (3) , 132-140
Redefining the paradigm of atypical hypoadrenocorticism in dogs
The recognition of apparent isolated glucocorticoid deficiency can be challenging in a clinical setting because of vague clinical signs. The difficulty associated with diagnosis is exacerbated by a lack of standardised terminology, and often incomplete investigation and characterisation of the disease. Additional testing is usually necessary to confirm the underlying cause, optimise therapy and provide an accurate prognosis. This review suggests a classification system based upon aetiology as well as electrolyte concentrations, and provides an overview of the clinical approach to the diagnosis and treatment of glucocorticoid deficiency in dogs.
- 2 March 2019
- Published by Mark Allen Group in Companion Animal
- Vol. 24 (3) , 132-140
Redefining the paradigm of atypical hypoadrenocorticism in dogs
The recognition of apparent isolated glucocorticoid deficiency can be challenging in a clinical setting because of vague clinical signs. The difficulty associated with diagnosis is exacerbated by a lack of standardised terminology, and often incomplete investigation and characterisation of the disease. Additional testing is usually necessary to confirm the underlying cause, optimise therapy and provide an accurate prognosis. This review suggests a classification system based upon aetiology as well as electrolyte concentrations, and provides an overview of the clinical approach to the diagnosis and treatment of glucocorticoid deficiency in dogs.
- Open Access
- 15 January 2018
- Published by Springer Nature in Irish Veterinary Journal
- Vol. 71 (1) , 2
Prevalence and risk factors for hyperthyroidism in Irish cats from the greater Dublin area
Hyperthyroidism is common in older cats. Prevalence varies geographically, but is anecdotally considered low in Ireland. The aim of this study was to document prevalence of hyperthyroidism in older cats in the greater Dublin area of Ireland and to assess environmental and clinical associations for development and identification of the disease. Primary-care veterinary practices were requested to select cats aged 10 years or older where blood sampling was being performed for health screening or clinical investigations. Surplus serum/plasma samples were submitted to University College Dublin Diagnostic Endocrine Laboratory for total thyroxine (T4) measurement. Cats were classified as hyperthyroid, equivocal or euthyroid based on a total T4 concentration (reference interval, 15–60 nmol/L), of >60 nmol/L, 30–60 nmol/L or 60%) may reflect failure to detect goitre and account for the perceived low prevalence of this condition in Ireland.
- 15 January 2018
- Published by Springer Nature in Irish Veterinary Journal
- Vol. 71 (1) , 2
Open AccessPrevalence and risk factors for hyperthyroidism in Irish cats from the greater Dublin area
Hyperthyroidism is common in older cats. Prevalence varies geographically, but is anecdotally considered low in Ireland. The aim of this study was to document prevalence of hyperthyroidism in older cats in the greater Dublin area of Ireland and to assess environmental and clinical associations for development and identification of the disease. Primary-care veterinary practices were requested to select cats aged 10 years or older where blood sampling was being performed for health screening or clinical investigations. Surplus serum/plasma samples were submitted to University College Dublin Diagnostic Endocrine Laboratory for total thyroxine (T4) measurement. Cats were classified as hyperthyroid, equivocal or euthyroid based on a total T4 concentration (reference interval, 15–60 nmol/L), of >60 nmol/L, 30–60 nmol/L or 60%) may reflect failure to detect goitre and account for the perceived low prevalence of this condition in Ireland.
- 28 August 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (9) , 333-337
Clinical and clinicopathological features of non‐suppurative meningoencephalitis in young greyhounds in Ireland
The clinical and clinicopathological features of non‐suppurative meningoencephalitis in 30 greyhounds were reviewed. The dogs were from 21 separate litters, comprised both sexes (16 males and 14 females) and ranged in age from five to 18 months. In 14 (66.7 per cent) litters, more than one case was suspected or confirmed, and the number of siblings affected within individual litters ranged from one to seven. Clinical signs were progressive and varied from five days to 12 months in duration; 12 dogs had signs of two weeks' duration or less. The rate of progression of signs was variable. Common features included dullness or lethargy (22), altered behaviour (21), proprioceptive and postural reaction deficits (18), circling (17), ataxia (17), decreased appetite (15) and weight loss (13). No consistent haematological or biochemical abnormalities were identified and serology failed to implicate Toxoplasma gondii or Neospora caninum . Cerebrospinal fluid analysis revealed mild or moderate mononuclear pleocytosis in 12 (70.6 per cent) of 17 dogs. No definitive antemortem diagnosis could be made in any affected dog.
- 28 August 2010
- Published by Wiley in Veterinary Record
- Vol. 167 (9) , 333-337
Clinical and clinicopathological features of non‐suppurative meningoencephalitis in young greyhounds in Ireland
The clinical and clinicopathological features of non‐suppurative meningoencephalitis in 30 greyhounds were reviewed. The dogs were from 21 separate litters, comprised both sexes (16 males and 14 females) and ranged in age from five to 18 months. In 14 (66.7 per cent) litters, more than one case was suspected or confirmed, and the number of siblings affected within individual litters ranged from one to seven. Clinical signs were progressive and varied from five days to 12 months in duration; 12 dogs had signs of two weeks' duration or less. The rate of progression of signs was variable. Common features included dullness or lethargy (22), altered behaviour (21), proprioceptive and postural reaction deficits (18), circling (17), ataxia (17), decreased appetite (15) and weight loss (13). No consistent haematological or biochemical abnormalities were identified and serology failed to implicate Toxoplasma gondii or Neospora caninum . Cerebrospinal fluid analysis revealed mild or moderate mononuclear pleocytosis in 12 (70.6 per cent) of 17 dogs. No definitive antemortem diagnosis could be made in any affected dog.